Submitted by web@researchtop... on Wed, 08/12/2020 - 12:34
- Listen to streaming audioright from your computer
- Download programto your desktop
- Subscribe to podcastto have this and future issues delivered to your iTunes library
| Track 1: | Introduction |
| Track 2: | Management of metastatic melanoma with BRAF mutation |
| Track 3: | Case from the community |
| Track 4: | Adjuvant and neoadjuvant treatment |
| Track 5: | Current and future use of checkpoint inhibition |
| FACULTY |
|
Michael B Atkins, MD Deputy Director Georgetown Lombardi Comprehensive Cancer Center William M Scholl Professor and Vice-Chair, Department of Oncology Professor of Medicine Georgetown University Medical Center Washington, DC |
|
Professor Georgina Long, AO, BSc, PhD, MBBS Co-Medical Director of Melanoma Institute Australia Chair of Melanoma Medical Oncology and Translational Research Melanoma Institute Australia and Royal North Shore Hospital The University of Sydney Sydney, Australia |
|
Jason J Luke, MD Associate Professor and Director of the Cancer Immunotherapeutics Center University of Pittsburgh Medical Center and Hillman Cancer Center Pittsburgh, Pennsylvania |
| MODERATOR |
| Neil Love, MD Research To Practice Miami, Florida |